Concepedia

Irmgard Hofmann

IH

Statistics

Publications

8

Citations

1K

H-Index

8

Active since

2004

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Novartis (United States)

MRC Laboratory of Molecular Biology

Boehringer Ingelheim (Austria)

Irmgard Hofmann is an author at Novartis (Switzerland) specializing in life sciences, molecular oncology, and cell biology.

Publications per year

2004–2022

8

Publications

8

Specific apoptosis induction by the dual PI3K/mTor inhibitor NVP-BEZ235 in HER2 amplified and PIK3CA mutant breast cancer cells

Saskia M. Brachmann, Irmgard Hofmann, Christian Schnell et al. · Proceedings of the National Academy of Sciences · 2009 · 319 citations · Full text

Life Sciences, Oncology, Pharmacology +17

An N-terminally acetylated Arf-like GTPase is localised to lysosomes and affects their motility

Irmgard Hofmann, Sean Munro · Journal of Cell Science · 2006 · 244 citations

Life Sciences, Cell Biology, Molecular Biology +16

Crosstalk of the mitotic spindle assembly checkpoint with p53 to prevent polyploidy

Celia Vogel, Anne Kienitz, Irmgard Hofmann et al. · Oncogene · 2004 · 167 citations

Life Sciences, Cell Biology, Molecular Biology +12

The Arl4 Family of Small G Proteins Can Recruit the Cytohesin Arf6 Exchange Factors to the Plasma Membrane

Irmgard Hofmann, Amanda L. Thompson, Christopher M. Sanderson et al. · Current Biology · 2007 · 131 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +8

K-RAS Mutant Pancreatic Tumors Show Higher Sensitivity to MEK than to PI3K Inhibition In Vivo

Irmgard Hofmann, Andreas Weiss, Gaëlle Elain et al. · PLoS ONE · 2012 · 69 citations · Full text

Medicine, Cancer Biology, Oncology +17

1–5 of 8